Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ: VRTX )

312.16 -2.08 (-0.66%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
BioNTech, Vertex Pharmaceuticals And Other Big Biotechnology Stocks From Benzinga's Most Accurate Analysts
Although US stocks closed mixed on Thursday, but healthcare stocks recorded gains, gaining over 0.2% in the previous session. Biotechnology stocks were among the top performers in the sector, adding... 
Via Benzinga
My 3 Biggest Stock Market Predictions for December
Rumors of the bear market's demise are being exaggerated, for now. 
Via The Motley Fool
If You Invested $10,000 in Vertex Pharmaceuticals 5 Years Ago, This Is How Much You Would Have Today
Vertex has climbed 45% this year, defying the bear market. 
Via The Motley Fool
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
This space is ripe with opportunities for investors. 
Via The Motley Fool
3 Growth Stocks That Are Too Cheap to Ignore
Overlooking these stocks in the current market could be a mistake. 
Via The Motley Fool
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $7,900 Today
 
Via Benzinga
6 Analysts Have This to Say About Vertex Pharmaceuticals
 
Via Benzinga
What 6 Analyst Ratings Have To Say About Vertex Pharmaceuticals
 
Via Benzinga
Looking for a Once-in-a-Decade Buying Opportunity? Buy These 3 Stocks Before 2023
Big things lie ahead for these market leaders. 
Via The Motley Fool
Uncertainty Grips Markets-On A Clear Day Maybe You Can See A Week Ahead
Healthcare stocks are now favored by many strategists because of their defensive nature and focus on US markets. 
Via Talk Markets
2 Stocks Near 52-Week Highs That Could Climb Higher
This pair of stocks are bucking the trend and they could climb even higher. 
Via The Motley Fool
Cathie Wood Is Selling This High-Flying Stock. Here's Why You Should Buy It Instead
The ARK Invest founder might regret trimming her position in this biotech stock. 
Via The Motley Fool
7 Stocks on the Perfect 10 List
Companies that have strong quality, value, or growth grades are the stocks to buy once markets recognize their business potential. 
Via InvestorPlace
How to Trade the High-Growth Biotech Sector in the Midst of a Bear Market
Biotech is an exciting and emerging space that’s attracted increasing investor interest in recent years. 
Via Benzinga
3 Unstoppable Growth Stocks to Buy and Hold
These businesses are built for the long run. 
Via The Motley Fool
Bear Market Blues? 3 of the Best Stocks to Own in 2023
2023 could be a big year for each of these healthcare companies. 
Via The Motley Fool
3 Top Growth Stocks to Buy Sooner Rather Than Later
There's no time like the present to invest in these great companies. 
Via The Motley Fool
2 Growth Stocks That Could Double in 2023
Both are lagging the market this year. 
Via The Motley Fool
2 Hot Growth Stocks That Can Continue to Soar in 2023
Next year could be another strong one for both of these businesses. 
Via The Motley Fool
Crispr Therapeutics Stock: Bull vs. Bear
Crispr shares have fallen about 20% so far this year. 
Via The Motley Fool
5 Top Stocks to Buy Before 2023
These stocks have what it takes to win over time. 
Via The Motley Fool
Vertex Pharmaceuticals: Buy at the High?
Vertex is submitting a potential blockbuster to regulators this month. 
Via The Motley Fool
Want $1 Million in Retirement? Invest $100,000 in These 3 Stocks and Wait a Decade
These top stocks could be wise additions to a well-rounded investment portfolio. 
Via The Motley Fool
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
These innovative stocks have plenty of growth for investors to tap into over the long term. 
Via The Motley Fool
Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
Neurocrine Biosciences trended higher with the broad market Thursday, coming within a penny of Tuesday’s high of $125.99. It is forming a bullish channel. 
Via MarketBeat
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 15 Years
Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 15 years by 11.12% on an annualized basis producing an average annual return of 17.93%. Currently, Vertex Pharmaceuticals... 
Via Benzinga
3 Top Healthcare Stocks Defying the Bear Market
These healthcare companies haven't been slowed by macroeconomic conditions. 
Via The Motley Fool
Vertex to Participate in Upcoming Investor Conferences
From Vertex Pharmaceuticals Incorporated
Via Business Wire
3 Healthcare Stocks That Could Go Parabolic
These beaten-down stocks are ready for a rebound. 
Via The Motley Fool
Got $1,000? 2 Smart Stocks to Consider Buying Right Now
Don't overlook these major healthcare names on your next stock-buying spree. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.